Twitter

Link your Twitter Account to Market Wire News


When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.


Be alerted of any news about your stocks and see what other stocks are trending.

home / news releases / igm biosciences unlikely to move the needle again in

SNY - IGM Biosciences: Unlikely To Move The Needle Again In 2024

Sanofi

2024-05-11 23:18:05 ET

Summary

  • IGM Biosciences is developing a different class of antibodies to improve on the classic IgG antibodies.
  • Their most advanced project, aplitabart, is being tested in a clinical trial for metastatic colorectal cancer.
  • The company has a decent cash position but faces risks in the high-risk disease area and uncertainty in its collaboration with Sanofi.

Topline Summary and Update

For further details see:

IGM Biosciences: Unlikely To Move The Needle Again In 2024
Stock Information
Company Name: Sanofi
Stock Symbol: SNY
Market: NASDAQ
Website: sanofi.com
Menu
SNY SNY Quote SNY Short SNY News SNY Articles SNY Message Board
Get SNY Alerts

News, Short Squeeze, Breakout and More Instantly...